1. Home
  2. RSLS

RSLS

ReShape Lifesciences Inc.

Logo ReShape Lifesciences Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-12-2024 10:29am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Founded: 2002 Country:
United States
United States
Employees: N/A City: SAN CLEMENTE
Market Cap: 3.9M IPO Year: 2007
Target Price: N/A AVG Volume (30 days): 662.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.91 EPS Growth: N/A
52 Week Low/High: $0.14 - $4.10 Next Earning Date: 05-13-2024
Revenue: $8,678,000 Revenue Growth: -22.79%
Revenue Growth (this year): 17.47% Revenue Growth (next year): 20.00%

Share on Social Networks: